Welcome to LookChem.com Sign In|Join Free
  • or
5-Bromo-4,6-dimethoxypyrimidine, 97%, is a high-purity organic compound with the chemical formula C6H7BrN2O2. It features a pyrimidine ring structure, which is a six-membered aromatic heterocyclic compound containing four carbon atoms and two nitrogen atoms. In this specific compound, the pyrimidine ring is substituted with a bromine atom at the 5th position, and two methoxy groups are attached at the 4th and 6th positions. The 97% purity indicates that the product contains a minimum of 97% of the desired compound, with the remaining 3% being other substances, possibly impurities or by-products from the synthesis process. This chemical is often used in the synthesis of various pharmaceuticals and other organic compounds due to its unique structure and reactivity.

4319-77-1

Post Buying Request

4319-77-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4319-77-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 4319-77-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,3,1 and 9 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 4319-77:
(6*4)+(5*3)+(4*1)+(3*9)+(2*7)+(1*7)=91
91 % 10 = 1
So 4319-77-1 is a valid CAS Registry Number.
InChI:InChI=1/C6H7BrN2O2/c1-10-5-4(7)6(11-2)9-3-8-5/h3H,1-2H3

4319-77-1Relevant academic research and scientific papers

COMPOUNDS AS MODULATORS OF ROR GAMMA

-

Page/Page column 131, (2019/03/28)

The present invention encompasses compounds of the formula (I)(I) wherein the variables are defined herein which are suitable for the modulation of RORγ and the treatment of diseases related to the modulation of RORγ. The present invention also encompasses processes of making compounds of formula (I) and pharmaceutical preparations containing them.

COMPOUNDS AS MODULATORS OF ROR GAMMA

-

Page/Page column 141-142, (2015/11/09)

The present invention encompasses compounds of the formula (I) wherein the variables are defined herein which are suitable for the modulation of RORγ and the treatment of diseases related to the modulation of RORγ. The present invention also encompasses processes of making compounds of formula (I) and pharmaceutical preparations containing them.

Triazolopyrimidine cannabinoid receptor 1 antagonists

-

Page/Page column 41, (2010/11/25)

The present application describes compounds according to both Formulas I and II, pharmaceutical compositions comprising at least one compound according to either Formula I or II and optionally one or more additional therapeutic agents, and methods of treatment using the compounds according to Formulas I and II both alone and in combination with one or more additional therapeutic agents. The compounds have the following general formulas: including all prodrugs, solvates, pharmaceutically acceptable salts and stereoisomers, wherein R1, R2, R3, R4 and R5 are described herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4319-77-1